SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating PI3K/Akt/mTOR pathway and ROS-mediated cell death
SOD1抑制剂通过调节PI3K/Akt/mTOR通路和ROS介导的细胞死亡，增强索拉非尼在HBV相关肝细胞癌中的疗效。
期刊:Journal of Cellular and Molecular Medicine
影响因子:4.3
doi:10.1111/jcmm.18533
Jooyoung Lee ,Jiye Kim ,Ryunjin Lee ,Eunkyeong Lee ,Hye-In An ,Yong-Jae Kwon ,Hana Jin ,Chan-Gi Pack ,Inki Kim ,Young-In Yoon ,Gil-Chun Park ,Eun-Kyoung Jwa ,Jae Hyun Kwon ,Jung-Man Namgoong ,Gi-Won Song ,Shin Hwang ,Eunyoung Tak ,Sung-Gyu Lee
PI3K/Akt
SOD1
细胞生物学
信号转导
肿瘤
肿瘤免疫
mTOR
